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1. Introduction 
Basic proteinase inhibitors of trypsin and related 
enzymes are widely distributed in the animal tissues 
including pancreas, lungs, parotide glands and liver [ 1 ]. 
A number of these have been purified and characterized, 
including their primary structures [2]. The use of 
these inhibitors as models for the study of structure- 
function relationships is particularly attractive. Pre- 
viously, two novel inhibitors which inhibit kallikrein, 
plasmin, c~-chymotrypsin and trypsin have been found 
in the venom of Russell's viper, and one of them de- 
signated as RVV inhibitor II was characterized to be 
a polypeptide consisting of 60 amino acid residues [3]. 
This paper describes the complete amino acid sequence 
and locations of disulfide bridges in the inhibitor. 
2. Materials and methods 
RVV inhibitor II previously isolated from 900 mg 
of the venom of Russell's viper (Sigma Chemical Co., 
St. Louis, lot, $62B-206) was used [3]. The amino 
acid composition of the inhibitor II determined with 
24, 48 and 72 hr hydrolyzates was as follows: Lys 3, 
His 2, Arg 7, Asp 8, Thr 3 , Ser 2 , Glu 5 , Pro 2, Gly 8 , Ala 2, 
½ Cys6, Vail, l|el, Leu3, Tyr 3 and Phe 4. TPCK-tryp- 
sin (twice crystallized) and a-chymotrypsin (three 
times crystallized) were products of Sigma Chemical 
Co., Thermolysin was a generous gift from Dr. K. 
Abbreviations: RVV, Russell's Viper Venom; PITC, Phenyliso- 
thiocyanate; PTH, Phenylthiohydantoin; Cm,S-carboxyl- 
methyl; PBTI, Pancreatic basic trypsin inhibitor; CTI, Colo- 
strum trypsin inhibitor; TPCK, L-(1-p-Toluenesulfonylamido- 
2-phenyl)-ethyl ch oromethyl ketone. 
Morihara, Shionogi Research Laboratory Co., Osaka. 
Carboxypeptidase A and B (DFP-treated) were ob- 
tained from Worthington Biochemical Corp, Freehold. 
Sephadex G-25 (superfine) was a product of Pharma- 
cia, Uppsala. 
The reduction and carboxymethylation of the in- 
hibitor II (2.9/amoles) were performed according to 
the method of Crestfield [4], and the resulting Cm- 
derivative was gel-filtrated on a Sephadex G-10 
column (2.0 × 130 cm) and eluted with 10% acetic 
acid. Digestions of the Cm-derivative with TPCK-tryp- 
sin and a-chymotrypsin were made in 0.2 M (NH4)HCO 3 
buffer, pH 8.5, at 37°C, and at 40°C thermolysin 
digestion with a substrate concentration f 0.5% (w/v) 
and an enzyme to substrate ratio of 1:50 in all the 
cases. Some peptide mixtures of the tryptic digest 
were separated by chromatography on a Dowex 50 
(X2) column (0.9 × 40 cm), equilibrated with pyri- 
dine acetate buffer, pH 3.05. The peptides were 
eluted by using a buffer gradient system described by 
lwanaga et al. [5]. The peptides were purified also by 
high-voltage paper (Toyo No. 51A) electrophoreses 
with pyridine acetate buffer, pH 3.4 and 6.4. Amino 
acid analysis was performed on samples, which were 
hydrolyzed at 110 ° in evacuated sealed tubes with 
5.7 N HC1 for 24 hr. Evaporated hydrolyzates were 
analyzed by an amino acid analyzer, Model JLC-5AH, 
Japan Electron Optics Laboratory Ltd., according to the 
method of Spackman et al. [6]. Amino acid sequence 
was analyzed by Edman's PITC procedures [7], and 
the resulting PTH amino acids were identified by thin- 
layer chromatography on silica gel plates (Kiesel gel 
F254), using solvents D and E of Edman and Sj6quist 
[8] and solvents II and III of Brenner et al. [9]. 
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Table 1 
Partial amino acid sequence of tryptic fragments of RVV inhibitor I. 
January 1974 
RW inhibitor II Hi~s-As___p-A~g-Pro--Thr-Phe- 
0.11 0.14 0.04 0.08 0.08 0.05 
T2 
T'-4 
T-4-4 
T-5-1 
T-5-2 
T-5-3 
T-5-4 
T-7-2 
T-7-3 
Hi s-A_.~-A_~-Pro-Thr-Phe-Cm-Asn-L~eu-A~,la (Glu, Gly, Ser, Pro)-Arg-OH 
0.26 0.30 0.16 0.18 0.14 0.16 0.12 0.10 0.07 0.05 
Val-Phe-Phe-Tyr-Gly-Gly-Cm-Gly-Gly-Asn(Ala, sn, Asn)Phe-Glu-Thr-Arg-OH 
0.38 0.25 0.20 0.17 0.13 0.08 0.12 0.04 0.02 0.01 0.15 0.06 
Gly--Hi__ss- Le___,u- Arg -OH 
0.23 0.10 0.04 
Gin-Thr-Cm-Gly-Gly-Lys-OH 
O.~6 0.0"2 0-01 
Asp-Glu-Cm-Arg-OH 
0.3~4 0.-~ 0.~-~ 
C_m.m-Lys-OH 
0.34 
I le-Tyr-Try-Asn-Leu-Glu-Ser-Asn-Lys-OH 
~.26 ~57.25 k~'o 0.-~ 0.~ 0.~ 0.~ 
Cm-Arg-OH 
0.14 O.O'3 
Arg-OH 
The amino acids cleaved by direct Edman procedure are indicated by arrows (---,) under which their molar ecovery is given. 
3. Results 
Using native RVV inhibitor II (0.4 ~tmoles), 
Edman's tepwise degradation was performed and the 
partial N-terminal sequence is given in table 1. In 
each degradation cycle one main PTH-derivative was 
released together with traces of other PTH amino 
acids. To determine the complete sequence of the 
inhibitor II, the Cm-derivative (2.8/amoles) was 
digested at 37°C for 6 hr by trypsin and a-chymo- 
trypsin, respectively. In the tryptic digest, peptide 
mixture was separated first on a Sephadex G-25 col- 
umn (2.0 X 140 cm) and some of the peptide frac- 
tions obtained were then separated by ion exchange 
chromatography on a Dowex 50 (X2) column. 
Through these procedures, eight major peptides and 
free arginine were isolated and their amino acid 
compositions are shown in table 2. A sum of the 
total residues of tryptic peptides agreed with whole 
amino acid composition of the starting material. Table 1 
shows also the amino acid sequences of tryptic peptides 
analyzed by PITC and carboxypeptidase m thods [ 10]. 
In these peptides, T -2  was deduced to be derived from 
the N-terminal part of the inhibitor II, as its 6 N- 
terminal sequences were identical to those of the 
native material. To obtain overlaps of the tryptic 
peptides, ct-chymotrypsin digest was separated with 
the same methods as those used on the tryptic di- 
gest. Six main peptides and free tyrosine and pheny- 
lalanine were isolated and their amino acid compo- 
sitions and partial sequences were determined, a-Chy- 
motryptic peptides, designated as C - l ,  C -8 -4 ,  
C -5 -3  and C-4 -2  (fig. 1), apparently constituted 
the overlaps of the tryptic peptides. From these 
results, all of the alignment of the tryptic peptides 
could be established. 
To determine the location of disulfide bridges 
and to confirm further the amino acid sequences 
deduced from the analyses of tryptic and ct-chymo- 
tryptic peptides, thermolytic digestion on native 
inhibitor II (1.1 gmoles) was performed at 40°C, 
pH 6.5, for 12 hr. The digest was first separated by 
218 
Volume 38, number 2 FEBS LETTERS 
Table 2 
Amino acid compositions of tryptic fragments of RVV inhibitor I. 
January 1974 
Amino acid T -2  T -4  T -4 -4  T -5 -1  T -5 -2  T -5 -3  T -5 -4  T -7 -2  T -7 -3  
residues/mole 
Asp 2.12 (2) 3.17 (3) 1.00 (1) 2.15 (2) 
Thr 0.97 (1) 1.05 (1) 1.05 (1) 
Ser 0.96 (1) 0.98 (1) 
Glu 1.08 (1) 1.11 (1) 1.13 (1) 1.05 (1) 1.10 (1) 
Pro 2.00 (2) 
Gly 1.17 (1) 4.24 (4) 1.00 (1) 2.18 (2) 0.13 
Ala 0.94 (1) 0.96 (1) 
Cm 0.93 (1) 0.90 (1) 0.82 (1) 0.99 (1) 0.96 (1) 1.00 (1) 
Val 0.94 (1) 
lie 1.00 (1) 
Leu 1.07 (1) 1.12 (1) 1.10 (1) 
Tyr 0.94 (1) 1.35 (1-2) 
Phe 1.04 (1) 2.94 (3) 
Lys 1.01 (1) 1.04 (1) 1.07 (1) 
His 0.90 (1) 0.90 (1) 
Arg 1.90 (2) 1.11 (1) 0.99 (1) 0.96 (1) 1.40 (1) 1.00 (1) 
NH3 1.90 2.7 1.26 3.14 0.89 0.84 2.96 1.24 1.39 
Total 15 17 4 6 4 2 8-9 2 1 
Yield (%) 50 29.5 36.2 14.7 44.25 39.8 28.5 37.2 27.2 
I 5 10 15 
N-His-Asp-Arg-Pro-Thr-Phe-Oys-Asn-Leu-Ala-Pro-Glu-Ser-Gly-Arg-  
• T -2  
C -7  ~ * C-  I 
TL-3-7 ~" ~--TL-3-3-A-~ ~ TL-4-8~--  
TL-2-5-A - -  
20 25 30 
Cys-Arg-Gly-H± s-Leu-Arg-Arg- I1 e-Tyr-Tyr-Asn-Leu-Glu-S er-Asn- 
~-T-7- 2-~ -~ T-4-4 ~T-7-3< T-5-4  
~ C-8-4 ~ @C-11 
(-TL-4-3~, w---TL- 3- 2 --~ -( 
35 40 45 
Lys-Cy s-Lys-Val-Phe-Phe-Tyr-Gly-Gly-C ys-Gly-Gly-A sn-Ala-A sn- 
~-T-5-3+ • T '-4 
- -C -5 -3  rC - IO  C-11 ~ C-9-2- 
-TL- I - I -A ~ ~ TL-2-5-B 
5O 55 6O 
A sn-Ph e-Glu-Thr-Arg-Asp-Glu-Cys-Arg-Glu-Thr-C ys-G1 y-Gly-Ly s-OH 
~ T-5-2 > ~ T-5-I 
4 C-4-2 
), .~-9L-6-2-~4 TL- I - I -E  ~. • TL-3-3-E r 
Fig. 1. Amino acid sequence of proteinase inhibitor II from the venom of Vipera russellL 
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gel filtration on a Sephadex G-25 column 
(1.5 × 110 cm), and then purified by high-v01tage 
paper electrophoresis at pH 3.4. Three major pep- 
tides positive to nitroprusside reaction were isolated 
and their amino acid compositions were determined. 
Moreover, on each of the peptides containing disul- 
fide bridges, performic oxidation was made. Two 
different cysteic acid peptides from each of the 
cystine peptides were isolated by high-voltage paper 
electrophoresis at pH 6.4, and their amino acid 
compositions and partial sequences were determined. 
These experiments made it possible to elucidate that 
three disulfide bridges in RVV inhibitor II are lo- 
cated as follows: Cys 7-Cys 57, Cys 16-Cys 40 
and Cys 32-Cys 53. 
4. Discussion 
Snake venom contains a number of physiologically 
active polypeptides including so-called neurotoxins, 
cardiotoxins and cytotoxins. The chemical structures 
of these polypeptidic toxins have recently been elu- 
cidated [ 11 ]. The proteinase inhibitor presented 
here is quite different substance from above compo- 
nents in its chemical structure and biological activity. 
Similar proteinase inhibitors have been found also 
in several venoms of the Elapidae family [12]. 
As previously reported [3], RVV inhibitor II 
combines with trypsin in a molar ratio of 1 : 1 and 
its inhibitory capacity seems identical with that of 
pancreatic secretary (Kazal type) and basic (Kunitz 
type) trypsin inhibitors. The chemical characteriza- 
tions of RVV inhibitor II indicate that the molecule 
is very similar to that of bovine PBTI. The N-termi- 
nal sequence of RVV inhibitor II was first deduced 
to be Asp-Asp-  by analysis with Edman degrada- 
tion [7]. However, further investigations on that 
part revealed the sequence of H is -Asp-  (fig. 1). 
The contradiction of these results could be con- 
sidered as an error due to the abnormal behaviour 
of histidyl peptides encountered often in the step- 
wise degradation technique [13]. The overall pri- 
mary structure of RVV inhibitor II has quite simi- 
larity to those of bovine PBTI [14, 15] and cow's 
colostrum trypsin inhibitor (CTI) [16]. The 6 half- 
cystine of three inhibitors occupy the same posi- 
tions in the amino acid sequences of these poly- 
peptides. Moreover, about 50% homology of the 
amino acid sequences between RVV inhibitor II and 
PBTI could be found, when chemical similarities are 
scored on the basis of Lys:Arg, Asp:Glu Asp:Asn, 
Glu:Gln Thr:Ser, Val:Ile, Ile:Leu and Tyr:Phe [17]. 
The reactive site of RVV inhibitor II is still unknown, 
but most probably site, which interacts with trypsin, 
would be a peptide linkage of Arg 17-Gly 18, be- 
cause the sequence homologies around this portion 
between two inhibitors are extremely high. During 
the course of this study, Strydom [18] reported 
that a large part of the amino acid sequences of 
toxins I and K, which were isolated from the venom 
of Dendroaspis polylepis (black Mamba), are very 
similar to those of PBTI and CTI. Differing from 
PBTI and CTI, those toxins were reported as mono- 
valent type proteinase inhibitor, since toxin K in- 
hibits only trypsin but not a-chymotrypsin, whereas 
the reverse is true on toxin I. Thus, RVV inhibitor 
II, which is a polyvalent rype inhibitor, seems to be 
much similar to PBTI and CTI. Their structural 
similarities also support his idea. 
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